RT Journal Article
SR Electronic
T1 COVID-19 Pandemic Impact on Sexually Transmitted Infection Testing in a College Setting
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.08.21264716
DO 10.1101/2021.10.08.21264716
A1 Marconi, Agustina
A1 Falk-Hanson, Elizabeth C
A1 Crass, Megan
A1 Campbell, Peter
YR 2021
UL http://medrxiv.org/content/early/2021/10/09/2021.10.08.21264716.abstract
AB Objective Assess the impact of the pandemic on STI (sexually transmitted infections) testing in a college health setting.Design Exploratory analysis of the number of STI tests done, positive rates for those tests and of percentage of “compliance to follow-up” from March to December 2020 and its comparison with historical data at the University Health Services, UW-Madison.Sample students’ STI tests during the analyzed period.Measurement Observed (2020) vs Expected (2015-2019, average) number of STI tests, positive rate, compliance to follow-up testing for STIs.Results There was a significant decrease in the number of tests done and increase of positive rate when compared to historical for total sample and per sex. There was a decrease in the percentage of follow-up for the entire sample and females and an increase for males.Conclusions Considering the three outcomes assessed, we observe an impact in STI testing during the pandemic. In concordance with national data, our analysis shows significant declines in STI testing and follow-up during 2020 compared to previous years and an increase in positivity rate. The finding of higher positivity with lower number of tests is likely due to triaging patients, facilitating testing for those at highest risk of infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The MR IRB of University of WI - Madison conducted a review of the above referenced initial application. The study was determined to meet the criteria for exempt human subjects research in accordance with the following category(ies) as defined under 45 CFR 46: (4) Secondary research on data or specimens (no consent required)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors